Review




Structured Review

Eli Lilly notch pathway signaling receptor inhibitor
Notch Pathway Signaling Receptor Inhibitor, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/notch+pathway+signaling+receptor+inhibitor/notch+pathway+signaling+receptor+inhibitor/pmc04027576-27-81-40
Average 90 stars, based on 1 article reviews
notch pathway signaling receptor inhibitor - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Inhibition of Notch Pathway Signaling: A One Compound Mission To Treat Cancer
Article Snippet: Title: Notch Pathway Signaling Inhibitor Compound Patent Application Number: WO 2013/016081 A1 Publication date: 31 January 2013 Priority Application: US 61/512,016 Priority date: 27 July 2011 US 61/560,486 16 November 2011 Inventors: Hipskind, P. A.; Stephenson, G. A. Assignee Company: Eli Lilly and Company; Lilly Corporate Center, Indianapolis, IN 46285, United States Disease Area: Cancer Biological Target: The Notch pathway signaling receptors Summary: The invention in this patent application is unique, as it relates to only one specific compound; the claimed compound I is a Notch pathway signaling receptor inhibitor that may potentially be used for the treatment of cancer.



Similar Products

90
Eli Lilly notch pathway signaling receptor inhibitor
Notch Pathway Signaling Receptor Inhibitor, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/notch+pathway+signaling+receptor+inhibitor/notch+pathway+signaling+receptor+inhibitor/pmc04027576-27-81-40
Average 90 stars, based on 1 article reviews
notch pathway signaling receptor inhibitor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results